Naltrexone and Memantine Effects on Alcohol Drinking Behaviors

Conditions

Alcohol Drinking

Trial Phase

Phase 2

Trial Purpose and Description

Trial Purpose

The purpose of this study is to evaluate the combined effects of the study medications naltrexone and memantine on alcohol drinking behaviors. Participants will be randomized to receive a combination of these medications over a one week period and then participate in a laboratory session. During this session, participants are given an initial drink of alcohol followed by the choice to drink up to 12 more drinks over a three-hour period. These medications are hypothesized to reduce craving and number of drinks consumed prior to and after exposure to the initial drink of alcohol and during the three hour drinking period.



Participation Guidelines

Age:
21 Years - 50 Years
Gender:
Both

Eligibility Criteria


Inclusion Criteria:

- Ages 21-50

- Able to read English at 6th grade level or higher and to complete study evaluations

- Regular alcohol drinker

Exclusion Criteria:

- Individuals who are seeking alcohol treatment

- Medical conditions that would contraindicate the use of study medication

- Regular use of other substances
Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Yale University
Dates:
January 2012
Last Updated:
August 19, 2013
Study HIC#:

Clinicaltrials.gov ID: NCT01519063